Evolutionary Genomics, Inc. (FNAM)

USD 0.0

(0.0%)

Long Term Debt Summary of Evolutionary Genomics, Inc.

  • Evolutionary Genomics, Inc.'s latest annual long term debt in 2022 was 3.74 Million USD , down 0.0% from previous year.
  • Evolutionary Genomics, Inc.'s latest quarterly long term debt in 2023 Q3 was - USD , down 0.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported annual long term debt of 3.74 Million USD in 2021, up 66.7% from previous year.
  • Evolutionary Genomics, Inc. reported annual long term debt of 2.24 Million USD in 2020, down 0.0% from previous year.
  • Evolutionary Genomics, Inc. reported quarterly long term debt of - USD for 2023 Q1, down -100.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported quarterly long term debt of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Evolutionary Genomics, Inc. (2022 - 2009)

Historical Annual Long Term Debt of Evolutionary Genomics, Inc. (2022 - 2009)

Year Long Term Debt Long Term Debt Growth
2022 3.74 Million USD 0.0%
2021 3.74 Million USD 66.7%
2020 2.24 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%

Peer Long Term Debt Comparison of Evolutionary Genomics, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD -233.329%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. 1.29 Million USD -189.764%
Biora Therapeutics, Inc. 43.73 Million USD 91.44%
Bio-Path Holdings, Inc. 10 Thousand USD -37337.47%
Better Therapeutics, Inc. 10.34 Million USD 63.822%
Calithera Biosciences, Inc. 136 Thousand USD -2652.755%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD -3011.957%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 56.929%
Evelo Biosciences, Inc. 48.87 Million USD 92.341%
Finch Therapeutics Group, Inc. 28.4 Million USD 86.819%
Galera Therapeutics, Inc. 151.04 Million USD 97.522%
Innovation1 Biotech Inc. 218.99 Thousand USD -1609.481%
Kiromic BioPharma, Inc. 911.5 Thousand USD -310.724%
Molecular Templates, Inc. 9.74 Million USD 61.571%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD -100.017%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 19.06 Million USD 80.365%
Panbela Therapeutics, Inc. 4.19 Million USD 10.736%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 104.33 Million USD 96.412%
Statera Biopharma, Inc. 11.43 Million USD 67.25%
TRACON Pharmaceuticals, Inc. 732 Thousand USD -411.441%
Trevena, Inc. 35.23 Million USD 89.374%
Vaxxinity, Inc. 13.26 Million USD 71.771%
Vaccinex, Inc. 26 Thousand USD -14299.027%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%